Rare diseases
Investigational molecules
Locations
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
BelgiumA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
BelgiumPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
BelgiumA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
BelgiumLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
BelgiumA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
BelgiumA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
BelgiumA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
BelgiumA study testing duvakitug for patients with moderately to severely active ulcerative colitis
BelgiumA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
BelgiumStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BelgiumA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
